Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
Drug firms 'block cheap medicine'
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
